Pharmaceutical Surfactants Market 2028 By Type, Application and Geography | The Insight Partners

report image

Pharmaceutical Surfactants Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Anionic Surfactants, Cationic Surfactants, Non-Ionic Surfactants, Amphoteric Surfactants, Macromolecule Surfactants, Others); Application (Gene Delivery, Intracellular Products Recovery, Antimicrobial Agents, Emulsifying Agents, Probiotic Preparations, Others) and Geography

Report Code: TIPRE00023218 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming


Surfactants are organic chemicals that are generally used in pharmaceuticals for the recovery of intracellular products and gene delivery. They can be utilized as an antimicrobial agent as they stop the nourishment of various pathogenic microbes such as bacteria, fungi, and viruses, etc., and make the pharmaceutical preparations free of microbes that are harmful. They can be categorized as anionic surfactants, non-ionic surfactants, and many more. The non-ionic surfactants are used for protein formulations in pharmaceuticals. The surfactants are also used for drug delivery, act as an adhesive agent and therapeutic agent. Gemini surfactants are used as a transfection agent for drug delivery and are one of the most active research areas.


The "Global Pharmaceutical Surfactants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the pharmaceutical surfactants market with detailed market segmentation by type, application, and geography. The report provides key statistics on the market status of the leading pharmaceutical surfactants market players and offers key trends and opportunities in the market.


  •  Based on type, the global pharmaceutical surfactants market is segmented into anionic surfactants, cationic surfactants, non-ionic surfactants, amphoteric surfactants, macromolecule surfactants and others.
  •  On the basis of application, the market is segmented into gene delivery, intracellular products recovery, antimicrobial agents, emulsifying agents, probiotic preparations and others.


  •   Growing incidences of respiratory distress syndrome and antimicrobial properties of pharmaceutical surfactants are expected to drive the pharmaceutical surfactants market growth.
  •   Increasing respiratory problems in neonates due to the alveolar surfactant deficiency and unique pharmaceutical surfactants property of emulsification and solubilization for protein formulations and drug delivery boost the market growth.
  •   The rising market for these products and increasing application in the cosmetics and medicine field propel market growth.
  •   Growing funding in research and development and clinical trial activities fuel the market growth.


  •   Strict regulatory guidelines regarding pharmaceutical surfactants product launch.


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The pharmaceutical surfactants market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the pharmaceutical surfactants market in these regions.


COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the COVID-19 outbreak, the country-wise lockdown was imposed with self-quarantine regulations, the supply chain was disrupted, and the market registered a certain level of decline in growth. As the biosurfactants have been found to act as effective drug delivery systems and maintain dose proportionality in the process. Finally, the potential of biosurfactants to exhibit medicinal qualities in the treatment of SARS-CoV-2 infection has increased its demand, and because of the removal of restrictive measures, the surfactants market may witness growth in coming years.

Get more information on this report :


The report covers key developments in the pharmaceutical surfactants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from pharmaceutical surfactants market are anticipated to have lucrative growth opportunities in the future with the rising demand for pharmaceutical surfactants in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the pharmaceutical surfactants market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  Akzo Nobel N.V.
  •  Evonik
  •  Croda International Plc.
  •  BASF SE
  •  Dow Chemical Company
  •  Jeneil Biotech
  •  Soliance, S.A.
  •  Ecover
  •  Ashland Global Holdings, Inc.
  •  Wacker Chemie AG

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Get more information on this report :

The List of Companies

1. Akzo Nobel N.V.
2. Evonik
3. Croda International Plc.
5. Dow Chemical Company
6. Jeneil Biotech
7. Soliance, S.A.
8. Ecover
9. Ashland Global Holdings, Inc.
10. Wacker Chemie AG
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
  • $3000
  • $4550
  • $6550
  • $8550

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount